These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3388187)

  • 21. [Serological evaluation of polyvalent A-C anti-meningococcal vaccine in Chile].
    García Moreno J; Prat Miranda MS; Vicent P; Calderón B
    Bol Oficina Sanit Panam; 1982 Aug; 93(2):149-57. PubMed ID: 6215047
    [No Abstract]   [Full Text] [Related]  

  • 22. Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines.
    Robbins JB; Schneerson R; Gotschlich EC; Mohammed I; Nasidi A; Chippaux JP; Bernardino L; Maiga MA
    Bull World Health Organ; 2003; 81(10):745-50; discussion 751-5. PubMed ID: 14758435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York.
    Weiss D; Stern EJ; Zimmerman C; Bregman B; Yeung A; Das D; Dentinger CM; Marx MA; Kornblum J; Lee L; Halse TA; Mayer LW; Hatcher CP; Theodore MJ; Schmink S; Harcourt BH; Zucker JR; Layton M; Clark TA;
    Clin Infect Dis; 2009 Apr; 48(7):894-901. PubMed ID: 19231975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is vaccination against meningitis useful? The findings of an investigation in the Sherbrooke region, Quebec.
    De Wals P; Allard MA; Guindon K; Mayrand L; Simard S; Black R
    Can Commun Dis Rep; 2002 Apr; 28(8):61-3. PubMed ID: 11974427
    [No Abstract]   [Full Text] [Related]  

  • 25. An outbreak of meningococcal meningitis in a prison (epidemiology and control).
    Sathe PV; Mugumdar RD; Mahurkar SD; Sengupta SR
    Indian J Public Health; 1971 Jul; 15(3):92-6. PubMed ID: 5154305
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clonal expansion of Neisseria meningitidis W135. Epidemiological implications for the African meningitis belt].
    du Châtelet IP; Alonso JM; Taha MK
    Bull Soc Pathol Exot; 2002 Dec; 95(5):323-4; discussion 324-5. PubMed ID: 12696368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surveillance of vaccine breakthrough cases following MeNZB vaccination.
    McNicholas A; Galloway Y; Martin D; Sexton K; O'Hallahan J
    N Z Med J; 2008 Apr; 121(1272):38-46. PubMed ID: 18425153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Meningococcal meningitis: bacterial virulence, antibodies or complement?].
    Pujadas Capmany R; Jané Pesquer J
    Med Clin (Barc); 1984 Nov; 83(16):671-3. PubMed ID: 6439961
    [No Abstract]   [Full Text] [Related]  

  • 29. [Meningococcal disease in the Netherlands: media hype, but not an epidemic].
    van Furth AM; Zaaijer HL
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1716-8. PubMed ID: 11572168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Meningococcal B vaccine].
    Hjøllund SB
    Ugeskr Laeger; 1994 May; 156(21):3196. PubMed ID: 8066842
    [No Abstract]   [Full Text] [Related]  

  • 31. Active hospital-based surveillance for meningococcal polysaccharide vaccine adverse events after an emergency mass immunization program, Edmonton, Alberta.
    Can Commun Dis Rep; 2005 Jun; 31(11):126-30. PubMed ID: 15940838
    [No Abstract]   [Full Text] [Related]  

  • 32. Cerebrospinal meningitis in the Central African Republic.
    Wkly Epidemiol Rec; 1992 Nov; 67(45):333-5. PubMed ID: 1419569
    [No Abstract]   [Full Text] [Related]  

  • 33. Meningitis epidemics in Africa: a brief overview.
    Teyssou R; Muros-Le Rouzic E
    Vaccine; 2007 Sep; 25 Suppl 1():A3-7. PubMed ID: 17643560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meningococcal C conjugate vaccine: the experience in England and Wales.
    Campbell H; Borrow R; Salisbury D; Miller E
    Vaccine; 2009 Jun; 27 Suppl 2():B20-9. PubMed ID: 19477053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospects for prevention of meningococcal meningitis.
    Perkins BA
    Lancet; 2001 Jul; 358(9278):255-6. PubMed ID: 11498206
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years.
    Galloway Y; Stehr-Green P; McNicholas A; O'Hallahan J
    Int J Epidemiol; 2009 Apr; 38(2):413-8. PubMed ID: 18988650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serogroup B meningococcal vaccines.
    Zimmer SM; Stephens DS
    Curr Opin Investig Drugs; 2006 Aug; 7(8):733-9. PubMed ID: 16955685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meningococcal disease: risk for international travellers and vaccine strategies.
    Wilder-Smith A
    Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meningococcal vaccines in prevention and control of meningitis.
    Saxena SN; Rawal IJ; Tripathi KK; Gupta P
    Indian Pediatr; 1985 Jun; 22(6):453-65. PubMed ID: 3938978
    [No Abstract]   [Full Text] [Related]  

  • 40. Infectious disease. An ill wind, bringing meningitis.
    Roberts L
    Science; 2008 Jun; 320(5884):1710-5. PubMed ID: 18583588
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.